PR
LinkedIn

Paulo Reis MD MBA

Vice President - Global Patient Safety - Immunology

Indianapolis, Indiana, United States · 1 connection

Eli Lilly and Company

Not on Unlinked · Imported profile. Is this you? Claim it

About

Physician-executive with 25+ years operating across clinical medicine, regulatory science, and pharmaceutical leadership. Currently VP, Global Patient Safety — Immunology at Eli Lilly, with a career spanning Medical Affairs, Clinical Development, and Drug Safety across Rheumatology, Gastroenterology, and Immunology. At Lilly, I have led Global and US Medical Affairs for a portfolio of major immunology assets — including the launches of Taltz (Psoriasis, PsA, AS, nr-axSpA) and Olumiant (RA) — and directed Medical Affairs strategy and execution across three therapeutic areas simultaneously. I have built and led large cross-functional teams, driven the transformation of the Medical Affairs function within a major business unit, and most recently taken accountability for global patient safety in Immunology. Earlier in my career, I served as Head of Division of Medicines for Human Use at INFARMED (the Portuguese Medicines Agency), representing Portugal at the EMA's CHMP and multiple scientific working groups — giving me a regulatory perspective few Medical Affairs or Safety leaders possess. I also hold an MBA and spent over a decade as a Business Unit Director with full P&L responsibili

Experience

Vice President - Global Patient Safety - ImmunologyEli Lilly and Company
Jan 2026
Vice President, Clinical Design - Immunology, Clinical DevelopmentEli Lilly and Company
Jun 2023 to Dec 2025
Vice President - Head of Global & US Medical Affairs - Immunology Business UnitEli Lilly and Company
Mar 2023 to Jun 2023
Head of Global & US Medical Affairs, Rheumatology, Gastroenterology & COVID-19, Immunology BUEli Lilly and Company
Mar 2022 to Feb 2023
Sr. Medical Director - Therap Area Leader - Rheumatology, Gastroenterology, COVID-19, Immunology BUEli Lilly and Company
Dec 2021 to Mar 2022
Sr. Medical Director - US Medical Affairs, Rheumatology, Gastroenterology & COVID-19, Immunology BUEli Lilly and Company
Mar 2021 to Dec 2021
Sr. Medical Director - US Medical Affairs, Rheumatology & COVID-19, Biomedicines BUEli Lilly and Company
Jun 2020 to Mar 2021
Sr. Medical Director - US Medical Affairs, Rheumatology, Biomedicines BUEli Lilly and Company
Apr 2018 to Jun 2020
Senior Medical Director - US Medical Affairs Dermatology & Inflammation, Biomedicines BUEli Lilly and Company
Sep 2017 to Apr 2018
Global Medical Launch Leader, Global Medical Affairs, Taltz (Dermatology & Rheumatology)Eli Lilly and Company
Feb 2017 to Aug 2017
Assoc. Global Medical Launch Leader, Global Medical Affairs, Olumiant (Psoriatic Arthritis & axSpA)Eli Lilly and Company
Dec 2016 to Feb 2017
Board Certified RheumatologistJosé de Mello Saúde
Jan 2014 to Nov 2016
Business Unit Director and Medical DirectorPopular Seguros
Aug 2006 to Nov 2016
Business Unit Director and Medical DirectorEurovida
Jan 2005 to Nov 2016
Emergency Medicine PhysicianHospital Beatriz Ângelo
Jun 2012 to Oct 2016
Emergency Medicine PhysicianUnidade Local de Saúde de Amadora/Sintra
Jul 1997 to Oct 2016
Independent Consultant for Pharma (Safety, Regulatory)Independent/Freelance
Mar 2005 to Sep 2016
Head of Division of Medicines for Human Use (Regulatory Agency)INFARMED, I.P.
Mar 2003 to Jan 2005
University of Coimbra - Invited Professor - RheumatologyUniversity of Coimbra
Sep 1999 to Jan 2005
RheumatologistHospital de Santa Maria
Jan 1991 to Jan 1998
Medical DoctorPortuguese Air Force
Sep 1990 to Nov 1991

Education

The Lisbon MBA Católica | Nova
Master of Business Administration (MBA), Management, Marketing
2008 to 2010
Instituto Superior de Gestão
Master of Business Administration (M.B.A.), Business Administration and Management, General
2003 to 2004
Portuguese Ministry of Health
Consultant, Rheumatology
1998 to 2006
University of Lisbon
Doctor of Medicine (MD), Medicine
1981 to 1987
University of Lisbon
Rheumatologist, Medicine
1996
University of Lisbon
Doctor of Medicine - MD, Rheumatology Residency Program
1991 to 1998